The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
Open accessAbstract
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome of exercise intolerance due to impaired myocardial relaxation and/or increased stiffness. Patient with HFpEF often show signs of chronic systemic inflammation and experimental studies show that interleukin-1 (IL-1), a key pro-inflammatory cytokine, impairs myocardial relaxation. The aim of the current study was to determine the effects of IL-1 blockade with anakinra on aerobic exercise capacity in patients with HFpEF and plasma C-reactive protein (CRP) >2 mg/l (reflecting increased IL-1 activity). Twelve patients were enrolled in a double-blind, randomized, placebo-controlled, cross-over trial and assigned 1:1 to receive one of the 2 treatments (anakinra 100 mg or placebo) for 14 days and then an additional 14 days of the alternate treatment (placebo or anakinra). Cardiopulmonary exercise testing (CPX) was performed at baseline, after the first 14 days and after the second 14 days. Placebo-corrected interval change in peak oxygen consumption (VO2) was chosen as primary endpoint. All 12 patients enrolled in the study and receiving treatment completed both phases, and experienced no major adverse events. Anakinra led to a statistically significant improvement in peak VO2 (+1.2 ml•kg−1•min−1, P=0.009), and a significant reduction in plasma CRP levels (−74%, P=0.006). The reduction in CRP levels was correlated with the improvement in peak VO2 (R=-0.60, P=0.002). Three patients (25%) had mild and self-limiting injection site reactions. In conclusion, IL-1 blockade with anakinra for 14 days significantly quenches the systemic inflammatory response and improves aerobic exercise capacity in patients with HFpEF and elevated plasma CRP levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antlanger, M., Aschauer, S., Kopecky, C., Hecking, M., Kovarik, J. J., Werzowa, J., Mascherbauer, J., Genser, B., Säemann, M. D., & Bonderman, D. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000473868 · Cited by 2,808
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P., Smiseth, O. A., De Keulenaer, G., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,679
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Self-citationHeart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Arena, R., Myers, J., Williams, M. A., Gulati, M., Kligfield, P., Balady, G. J., Collins, E., & Fletcher, G. (2007) · Circulation · doi:10.1161/circulationaha.106.184461 · Cited by 727
Self-citationClinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay
Rifai, N., Tracy, R. P., & Ridker, P. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.12.2136 · Cited by 613
Obesity and suppressed B-type natriuretic peptide levels in heart failure
Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., & Frohlich, E. D. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.066 · Cited by 534
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Self-citationAbbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
Self-citationSwank, A. M., Horton, J., Fleg, J. L., Fonarow, G. C., Keteyian, S., Goldberg, L., Wolfel, G., Handberg, E. M., Bensimhon, D., Illiou, M.-C., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.965186 · Cited by 374
Ikonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.731877 · Cited by 307
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
Self-citationAnjan, V. Y., Loftus, T. M., Burke, M. A., Akhter, N., Fonarow, G. C., Gheorghiade, M., & Shah, S. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.014 · Cited by 286
Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance
Poole, D. C., Hirai, D. M., Copp, S. W., & Musch, T. I. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00943.2011 · Cited by 285
Arena, R., Myers, J., & Guazzi, M. (2008) · Heart Failure Reviews · doi:10.1007/s10741-007-9067-5 · Cited by 268
Self-citationVan Tassell, B. W., Arena, R. A., Toldo, S., Mezzaroma, E., Azam, T., Seropian, I. M., Shah, K., Canada, J., Voelkel, N. F., Dinarello, C. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033438 · Cited by 232
Self-citationDavies, L. C., Wensel, R., Georgiadou, P., Cicoira, M., Coats, A. J. S., Piepoli, M. F., & Francis, D. P. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi672 · Cited by 219
McMurray, J. J. V., Kjekshus, J., Gullestad, L., Dunselman, P., Hjalmarson, A., Wedel, H., Lindberg, M., Waagstein, F., Grande, P., Hradec, J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.849117 · Cited by 163
Cahalin, L. P., Chase, P. J., Arena, R. A., MYERS, J. N., Bensimhon, D., Peberdy, M. A., Ashley, E. A., West, E., Forman, D. E., Pinkstaff, S. O., et al. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9332-0 · Cited by 153
Self-citationIncreased prevalence of diastolic dysfunction in rheumatoid arthritis
Liang, K. P., Myasoedova, E., Crowson, C. S., Davis, J. M., Roger, V. L., Karon, B. L., Borgeson, D. D., Therneau, T. M., Rodeheffer, R. J., & Gabriel, S. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.124362 · Cited by 129
Interleukin-1β induces a reversible cardiomyopathy in the mouse
Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Mezzaroma, E., & Abbate, A. (2013) · Inflammation Research · doi:10.1007/s00011-013-0625-0 · Cited by 128
Self-citationHeart Failure With Preserved Ejection Fraction
Udelson, J. E. (2011) · Circulation · doi:10.1161/circulationaha.111.071696 · Cited by 114
Redfield, M. M., Borlaug, B. A., Lewis, G. D., Mohammed, S. F., Semigran, M. J., LeWinter, M. M., Deswal, A. M., Hernandez, A. F., Lee, K. L., & Braunwald, E. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.969071 · Cited by 110
Maeder, M. T., Rickenbacher, P. R., Rickli, H., Abbühl, H., Gutmann, M., Erné, P., Vuilliomenet, A., Peter, M., Pfisterer, M. E., Rocca, H. B., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft076 · Cited by 82
The analysis of data from 2 × 2 cross‐over trials with baseline measurements
Kenward, M. G., & Jones, B. C. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060806 · Cited by 81
High-Sensitivity C-Reactive Protein and Parameters of Left Ventricular Dysfunction
Shah, S. J., Marcus, G. M., Gerber, I. L., McKeown, B. H., Vessey, J. C., Jordan, M. V., Huddleston, M., Foster, E., Chatterjee, K., & Michaels, A. D. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.08.003 · Cited by 74
Predictive value of high sensitivity CRP in patients with diastolic heart failure
Michowitz, Y., Arbel, Y., Wexler, D., Sheps, D. S., Rogowski, O., Shapira, I., Berliner, S. A., Keren, G., George, J., & Roth, A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.037 · Cited by 65
Arena, R. A., Humphrey, R. H., & Peberdy, M. A. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00010 · Cited by 25
Self-citation
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Murphy, S. P., Kakkar, R., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 738
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Abbate, A., Toldo, S., Marchetti, C., Kron, J., Van Tassell, B. W., & Dinarello, C. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.315937 · Cited by 730
Self-citationSano, S., Oshima, K., Wang, Y., MacLauchlan, S., Katanasaka, Y., Sano, M., Zuriaga, M. A., Yoshiyama, M., Goukassian, D., Cooper, M. A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.037 · Cited by 699
Innate Immunity and the Failing Heart: The Cytokine Hypothesis Revisited
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 689
Metadata
- Authors
- Van Tassell, B. W., Arena, R., Biondi-Zoccai, G., McNair Canada, J., Oddi, C., Abouzaki, N. A., Jahangiri, A., Falcao, R. A., Kontos, M. C., Shah, K. B., Voelkel, N. F., Dinarello, C. A., & Abbate, A.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 113
- Issue
- 2
- Pages
- 321-327
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2171449411
- Cited by
- 281
- References
- 29
- FWCI
- 38.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.